Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia?

References

1. 1.↵
   2. Conde Cardona G,
   3. Quintana Pajaro LD,
   4. Quintero Marzola ID, et al

   . Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci 2020;412:116824 doi:10.1016/j.jns.2020.116824 pmid:32299010

   CrossRefPubMed
2. 2.↵
   2. Hoffmann M,
   3. Kleine-Weber H,
   4. Schroeder S, et al

   . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271–80.e278 doi:10.1016/j.cell.2020.02.052 pmid:32142651

   CrossRefPubMed
3. 3.↵
   2. Xia H,
   3. Lazartigues E

   . Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem 2008;107:1482–94 doi:10.1111/j.1471-4159.2008.05723.x pmid:19014390

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Hung EC,
   3. Chim SS,
   4. Chan PK, et al

   . Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 2003;49:2108–09 doi:10.1373/clinchem.2003.025437 pmid:14633896

   FREE Full Text
5. 5.↵
   2. Mao L,
   3. Jin H,
   4. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020 Apr 10. [Epub ahead of Print] doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
6. 6.↵
   2. De Felice FG,
   3. Tovar-Moll F,
   4. Moll J, et al

   . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci 2020;43:355–57 doi:10.1016/j.tins.2020.04.004 pmid:32359765

   CrossRefPubMed
7. 7.↵
   2. Poyiadji N,
   3. Shahin G,
   4. Noujaim D, et al

   . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 Mar 31. [Epub ahead of Print] doi:10.1148/radiol.2020201187] pmid:32228363

   CrossRefPubMed
8. 8.↵
   2. Ye M,
   3. Ren Y,
   4. Lv T

   . Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 2020 Apr 10. [Epub ahead of Print] doi:10.1016/j.bbi.2020.04.017 pmid:32283294

   CrossRefPubMed
9. 9.↵
   2. Zanin L,
   3. Saraceno G,
   4. Panciani PP, et al

   . SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020 May 4. [Epub ahead of Print] doi:10.1007/s00701-020-04374-x pmid:32367205

   CrossRefPubMed
10. 10.↵
    2. Moriguchi T,
    3. Harii N,
    4. Goto J, et al

    . A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–58 doi:10.1016/j.ijid.2020.03.062 pmid:32251791

    CrossRefPubMed
11. 11.↵
    2. Sachs JR,
    3. Gibbs KW,
    4. Swor DE, et al

    . COVID-19-associated leukoencephalopathy. Radiology 2020 May 14. [Epub ahead of Print] doi:10.1148/radiol.2020201753 pmid:32407258

    CrossRefPubMed
12. 12.↵
    2. Kandemirli SG,
    3. Dogan L,
    4. Sarikaya ZT, et al

    . Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020 May 8. [Epub ahead of Print] doi:10.1148/radiol.2020201697 pmid:32384020

    CrossRefPubMed
13. 13.↵
    2. Helms J,
    3. Kremer S,
    4. Merdji H, et al

    . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70 doi:10.1056/NEJMc2008597 pmid:32294339

    CrossRefPubMed
14. 14.↵
    2. Oxley TJ,
    3. Mocco J,
    4. Majidi S, et al

    . Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020;382:e60 doi:10.1056/NEJMc2009787 pmid:32343504

    CrossRefPubMed
15. 15.↵
    2. Jain R,
    3. Young M,
    4. Dogra S, et al

    . COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020;414:116923 doi:10.1016/j.jns.2020.116923 pmid:32447193

    CrossRefPubMed
16. 16.↵
    2. Marini JJ,
    3. Gattinoni L

    . Management of COVID-19 respiratory distress. JAMA 2020 April 24. [Epub ahead of Print] doi:10.1001/jama.2020.6825 pmid:32329799

    CrossRefPubMed
17. 17.↵
    2. Sarbu N,
    3. Shih RY,
    4. Jones RV, et al

    . White matter diseases with radiologic-pathologic correlation. Radiographics 2016;36:1426–47 doi:10.1148/rg.2016160031 pmid:27618323

    CrossRefPubMed
18. 18.↵
    2. Beeskow AB,
    3. Oberstadt M,
    4. Saur D, et al

    . Delayed post-hypoxic leukoencephalopathy (DPHL): an uncommon variant of hypoxic brain damage in adults. Front Neurol 2018;9:708 doi:10.3389/fneur.2018.00708 pmid:30210433

    CrossRefPubMed
19. 19.↵
    2. Mehta P,
    3. McAuley DF,
    4. Brown M, et al

    ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–34 doi:10.1016/S0140-6736(20)30628-0 pmid:32192578

    CrossRefPubMed